Healthcare -
Biotechnology - NASDAQ - US
$ 2.95
-10.3 %
$ 2.15 B
Market Cap
-3.28
P/E
IBRX - TOTAL LIABILITIES & EQUITY
Total Liabilities & Equity IBRX - ImmunityBio, Inc.
504 M
LAST VALUE
3.72%
2 YEAR CAGR
22.62%
5 YEAR CAGR
72.98%
10 YEAR CAGR